{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:04:38Z","timestamp":1790949878613,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The prognosis of patients with rheumatoid arthritis (RA) complicated with interstitial lung disease (ILD) is very poor. We used blood protein profiles to identify biomarkers for ILD in patients with RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Proteome analyses of plasma samples from 16 RA patients with ILD or without chronic lung disease (CLD) were performed with a proteomic assay using antibody immunoassay and next generation sequencing. Validation of the results was achieved by multiplex bead-based immunoassay of 20 candidate protein biomarkers in serum of 96 RA patients with ILD or without CLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Levels of carbohydrate antigen 125 (CA125), C-X-C motif chemokine ligand (CXCL)9, CXCL13, interleukin (IL)-19, tissue inhibitor of metalloproteinase (TIMP)-1, TIMP-2, and TIMP-4 were increased and those of C-C motif chemokine ligand (CCL)3 were decreased in RA with ILD compared with those without CLD. Multiple logistic regression analysis of CXCL9, CXCL13, and TIMP-1 was performed to generate an ILD-index. The area under the curve value of receiver operating characteristic curve of ILD-index was 0.818 (95% confidence interval 0.730\u20130.907).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Blood biomarker profiles could represent diagnostic biomarkers for ILD in RA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1890259","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:49:11Z","timestamp":1786549751000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Blood protein biomarkers for rheumatoid arthritis patients complicated by interstitial lung disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Hiroshi","family":"Furukawa","sequence":"first","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital","place":["Kiyose, Japan"]},{"name":"Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital","place":["Sagamihara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Hikichi","sequence":"additional","affiliation":[{"name":"Tuning Fork Bio Japan, MITSUI LINK-Lab SHINKIBA 2","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kunieda","sequence":"additional","affiliation":[{"name":"Tuning Fork Bio Japan, MITSUI LINK-Lab SHINKIBA 2","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shomi","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital","place":["Kiyose, Japan"]},{"name":"Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital","place":["Sagamihara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital","place":["Kiyose, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Sagamihara National Hospital","place":["Sagamihara, Japan"]},{"name":"Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center","place":["Fuchu, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Sagamihara National Hospital","place":["Sagamihara, Japan"]},{"name":"Department of Internal Medicine, Sagami Seikyou Hospital","place":["Sagamihara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Komiya","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital","place":["Sagamihara, Japan"]},{"name":"Department of Clinical Laboratory, NHO Sagamihara National Hospital","place":["Sagamihara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Matsui","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital","place":["Sagamihara, Japan"]},{"name":"Department of Rheumatology, NHO Sagamihara National Hospital","place":["Sagamihara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoshi","family":"Fukui","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital","place":["Sagamihara, Japan"]},{"name":"Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital","place":["Kiyose, Japan"]},{"name":"Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital","place":["Sagamihara, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, NHO Tokyo National Hospital","place":["Kiyose, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e33133","DOI":"10.1371\/journal.pone.0033133","article-title":"Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope","volume":"7","author":"Furukawa","year":"2012","journal-title":"PLoS One."},{"key":"B2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/03009740310004621","article-title":"Epidemiology of extra-articular manifestations in rheumatoid arthritis","volume":"33","author":"Turesson","year":"2004","journal-title":"Scand J Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1000064","DOI":"10.4172\/1745-7580.1000064","article-title":"Plasma amino acid profiles in collagen disease patients with interstitial lung disease","volume":"9","author":"Furukawa","year":"2013","journal-title":"Immunome Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/thorax-2021-217822","article-title":"Fr\u00edas S, Easthausen I, Hoffman K, Oromendia C, et al. Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis","volume":"77","author":"Wu","year":"2022","journal-title":"Thorax."},{"key":"B6","doi-asserted-by":"publisher","first-page":"117506","DOI":"10.1016\/j.cca.2023.117506","article-title":"Identification of novel candidate biomarkers for acute myocardial infarction by the Olink proteomics platform","volume":"548","author":"Liu","year":"2023","journal-title":"Clin Chim Acta."},{"key":"B7","doi-asserted-by":"publisher","first-page":"107331","DOI":"10.1016\/j.rmed.2023.107331","article-title":"Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes","volume":"217","author":"Keur","year":"2023","journal-title":"Respir Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3892\/br.2025.2065","article-title":"Proteomic analysis identifies novel molecular signatures and immune-metabolic pathways in rheumatoid arthritis-associated interstitial lung disease","volume":"23","author":"Cui","year":"2025","journal-title":"Biomed Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2576636","DOI":"10.1080\/07853890.2025.2576636","article-title":"A clinically applicable method for early interstitial lung disease detection in incident rheumatoid arthritis cases: integration of protein biomarkers and clinical factors","volume":"57","author":"Gou","year":"2025","journal-title":"Ann Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"B12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1148\/radiol.2321030174","article-title":"Rheumatoid arthritis-related lung diseases: CT findings","volume":"232","author":"Tanaka","year":"2004","journal-title":"Radiology."},{"key":"B13","first-page":"1513","article-title":"Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis","volume":"35","author":"Mori","year":"2008","journal-title":"J Rheumatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/rheumatology\/kew025","article-title":"Association of human leukocyte antigen alleles with chronic lung diseases in rheumatoid arthritis","volume":"55","author":"Oka","year":"2016","journal-title":"Rheumatology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1021\/pr050300l","article-title":"Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics","volume":"5","author":"Callister","year":"2006","journal-title":"J Proteome Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics."},{"key":"B17","doi-asserted-by":"publisher","first-page":"026","DOI":"10.1038\/s41598-026-45180-2","article-title":"Protein microarray-based profiling of salivary IgA antibodies against human proteins in COVID-19 patients with depressive symptoms","volume":"23","author":"Hikichi","year":"2026","journal-title":"Sci Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Statist Soc B."},{"key":"B19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s11306-012-0482-9","article-title":"Translational biomarker discovery in clinical metabolomics: an introductory tutorial","volume":"9","author":"Xia","year":"2013","journal-title":"Metabolomics."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.3390\/biomedicines13112656","article-title":"Predicting and treating pulmonary fibrosis with proteomic biomarker investigations","volume":"13","author":"Raineri","year":"2025","journal-title":"Biomedicines"},{"key":"B21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/art.38904","article-title":"Biomarkers of rheumatoid arthritis-associated interstitial lung disease","volume":"67","author":"Chen","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","article-title":"Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases","volume":"165","author":"Ohnishi","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"021","DOI":"10.1007\/s40744-021-00288-x","article-title":"Serum KL-6, CA19-9, CA125 and CEA are Diagnostic biomarkers for rheumatoid arthritis-associated interstitial lung disease in the Chinese population","volume":"2021","author":"Zheng","year":"2021","journal-title":"Rheumatol Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/art.41123","article-title":"Comparative profiling of serum protein biomarkers in rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis","volume":"72","author":"Kass","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B26","first-page":"1164","article-title":"KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases","volume":"27","author":"Nakajima","year":"2000","journal-title":"J Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12931-025-03418-z","article-title":"Large scale plasma proteomic profiles improve prediction of idiopathic pulmonary fibrosis in general population","volume":"26","author":"Zhou","year":"2025","journal-title":"Respir Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2172-14-9","article-title":"Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease","volume":"14","author":"Oka","year":"2013","journal-title":"BMC Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e70162","DOI":"10.1111\/eci.70162","article-title":"Fibroblast-driven MMP-9\/TIMP-1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung disease","volume":"56","author":"Bertolotto","year":"2026","journal-title":"Eur J Clin Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0241719","DOI":"10.1371\/journal.pone.0241719","article-title":"CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features","volume":"15","author":"Kameda","year":"2020","journal-title":"PLoS One."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/exd.13724","article-title":"CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis","volume":"27","author":"Taniguchi","year":"2018","journal-title":"Exp Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00408-024-00694-2","article-title":"Pursuing clinical predictors and biomarkers for progression in ILD: analysis of the pulmonary fibrosis foundation (PFF) registry","volume":"202","author":"Chang","year":"2024","journal-title":"Lung."},{"key":"B33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2014a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J Exp Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41467-025-67814-1","article-title":"Cross-ancestry comparison of aptamer and antibody protein measures","volume":"17","author":"Nicholas","year":"2026","journal-title":"Nat Commun."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1890259\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:49:13Z","timestamp":1786549753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1890259\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":35,"alternative-id":["10.3389\/fmed.2026.1890259"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1890259","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1890259"}}